ETFDH and epilepsy: The preliminary study of DrugBank data and the results in this paper indicate that ETFDH, the target of metformin, is associated with an elevated risk of epilepsy and that metformin has a potential therapeutic value for epilepsy, although the specific mechanism still needs to be further explored.